摘要
该文介绍了厄他培南的合成路线。可用不同的路线合成含有不同保护基的厄他培南侧链,再由培南母核MAP和厄他培南侧链反应得到厄他培南。
出处
《中国药业》
CAS
2009年第9期87-88,共2页
China Pharmaceuticals
参考文献14
-
1陈章景,施耀国.新型碳青霉烯类抗生素厄他培南[J].中国抗感染化疗杂志,2004,4(4):251-256. 被引量：12
-
2张义凤,陈昊,彭久合,高瑞昶,张广明.碳青霉烯类抗生素厄他培南的合成[J].中国药科大学学报,2007,38(4):305-310. 被引量：6
-
3Nishino Y, Komurasaki T, Yuasa T, et al. Practical large- sacle synthesis of the a - aminomethylpyrrolidin - 4 - yl - thio - containing side chain of the novel carbapenem antibiotic coripenem[J]. Org Process Res Dev, 2003, 7(5): 649 -654.
-
4Semple G, Ryder H, Rooker DP, et al. (3R) -N- (1 - (tert- Butyl- carbonylmethyl) - 2, 3 - dihydro - 2 - oxo - 5 - (2 - pyridyl) - 1H - 1,4 - benzodiazepine - 3 - yl ) - N - ( 3 - ( methylamino ) phenyl ) urea (YF476) : a potent and orally active gastrin/CCK-B antagonist[J].J Med Chem, 1997, 40(3): 331 - 341.
-
5Mu F, Coifing SL, Riese II DJ, et al. Design, synthesis, and biological e- valuation of a series of lavendustin a analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization[J]. J Med Chem, 2001,44 (3) : 441 - 452.
-
6华更红,罗丽,刘德龙,谢芳,张万斌.(2S,4S)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的合成工艺改进[J].化学试剂,2007,29(2):124-126. 被引量：3
-
7上海交通大学.尔他培南的中间体N-保护-(2S,4S)-2-[(3-羟基羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇:中国,200510030663[P]2006-03-29.
-
8Sunagawa M, Matsumura H, Inoue T, et al. A novelcarbapenem antibiotic, SM27338 structure activity relationships[J]. J Antibiot, 1990, 43(5): 519 -532.
-
9仲兆金,武燕彬,刘浚.艾他培南关键中间体的合成[J].中国药物化学杂志,2006,16(2):82-84. 被引量：6
-
10Sorbera LA, Rabasseda X, Castaner J, et al. MK20826[J]. Drugs Future, 2000, 25(8): 795 - 802.
二级参考文献48
-
1陈章景,施耀国.新型碳青霉烯类抗生素厄他培南[J].中国抗感染化疗杂志,2004,4(4):251-256. 被引量：12
-
2石和鹏,冯彩虹,金洁,刘浚.新型1β-甲基碳青霉烯类抗生素厄他培南[J].中国新药杂志,2004,13(12):1172-1175. 被引量：14
-
3仲兆金,武燕彬,刘浚.艾他培南关键中间体的合成[J].中国药物化学杂志,2006,16(2):82-84. 被引量：6
-
4[1]Kohler J, Dorso KL, Young K, et al. In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolate[J]. Antimicrob Agents Chemother, 1999,43:1170-1176
-
5[2]Friedland IR, Isaacs R, Mixson LA, et al. Use of surrogate antimicrobial agents to predict susceptibility to ertapenem[J]. Diagn Microbiol Infect Dis, 2002,43:61-64
-
6[3]Vetter N, Cambronero-Hernandez E, Rohlf J, et al. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia[J]. Clin Ther,2002,24:1770-1785
-
7[4]Aldridge KE. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes[J]. Diagn Microbiol Infect Dis, 2002,44:181-186
-
8[5]Fuchs PC, Barry AL, Brown SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers[J]. Antimicrob Agents Chemother,2001,45 : 1915-1918
-
9[6]Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia[J]. Antimicrob Agents Chemother,2001,45:1860-1867
-
10[7]Goldstein EJ, Citron DM, Vreni Merriam C, et al. Comparative In vitro activities of ertapenem (MK-0826) against 1,001anaerobes isolated from human intra-abdominal infections[J].Antimicrob Agents Chemother, 2000,44: 2389-2394
共引文献19
-
1田宜玄,解沛涛,刘俊保,苏长海.1例人工关节置换术后应用厄他培南致神经系统异常的病例分析及药学监护[J].疾病监测与控制,2023,17(1):4-7.
-
2于亮,王梅,李玉臣,袁军,张利,鲍文韬,贾健,张莹,吴鹏.2007～2010年泰安医院临床主要病原菌分布及两种主要非发酵菌的耐药分析[J].中华临床医师杂志（电子版）,2011,5(16):4766-4769. 被引量：15
-
3于瑞,王兴涌.各类氨基酸的应用研究进展[J].化工中间体,2011,7(10):13-17. 被引量：6
-
4吕艳霞.厄他培南——治疗多重耐药菌感染的新选择[J].海峡药学,2007,19(1):62-64. 被引量：2
-
5华更红,罗丽,刘德龙,谢芳,张万斌.(2S,4S)-1-(4-硝基苄氧羰基)-2-[(3-烯丙氧羰基)-苯基氨基甲酰基]-吡咯烷-4-基硫醇的合成工艺改进[J].化学试剂,2007,29(2):124-126. 被引量：3
-
6张义凤,陈昊,彭久合,高瑞昶,张广明.碳青霉烯类抗生素厄他培南的合成[J].中国药科大学学报,2007,38(4):305-310. 被引量：6
-
7来小丹,刘松青,林彩.新型碳青霉烯类抗生素厄他培南[J].中国药业,2007,16(23):1-3. 被引量：17
-
8罗涛,黄文祥,吴利先.注射用法罗培南的体内抗菌活性[J].中国新药与临床杂志,2008,27(3):183-186.
-
9邢春燕,崔纪云,李军,王欣.厄他培南治疗老年人社区获得性肺炎[J].中华老年医学杂志,2009,28(10):845-846. 被引量：3
-
10张倩,胡浩鹏,薛载坤,孙成瑞,张津枫,邓杰.(2S)-cis-3-[[(2-吡咯烷基-4-巯基)羰基]氨基]苯甲酸盐酸盐的合成[J].河南师范大学学报（自然科学版）,2011,39(1):116-118.
同被引文献31
-
1Bassetti M, Nicolini L, Esposito S, et al. Current status of newer carbapenems [ J ]. Curr Med Chem, 2009, 16 ( 5 ) :564-575.
-
2Zhang R,Yang L J,Cai J C,et al. High-level carbapenem resistance in a Citrobacterfreundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression [ J ]. J Med Microbiol,2008 ,57 ( 3 ) : 332-337.
-
3Coulthurst S J, Bamard A M L, Salmond G P C. Regulation and Biosynthesis of carbapenem antibiotics in bacteria [ J]. Nat Rev Microbiol,2005,3:295-306.
-
4Hamed R B, Batchelar E T, Mecinovic J, et al. Evidence that thienamycin biosynthesis proceeds via C-5 epimeriza- tion:thne catalyzes the formation of (2S, 5S)-trans-car- boxymethylproline [ J ]. Chembiochem, 2009, 10 ( 2 ) : 246-250.
-
5Batchelar E T, Hamed R B, Ducho C, et al. Thioester hydrolysis and C-C bond formation by carboxymethylpro- line synthase from the crotonase superfamily [ J ]. Angew Chem Int Ed,2008,47(48) :9322-9325.
-
6Sleeman M C, Schofield C J. Carboxymethylproline syn- thase (CarB), an unusual carbon-carbon bond-forming enzyme of the crotonase superfamily involved in carbapen- em biosynthesis [ J ]. J Biol Chem, 2004, 279 ( 8 ) : 6730 - 6736.
-
7Miller M T, Gerratana B, Stapon A, et al. Crystal structure of carbapenam synthetase (CarA) [ J ]. J Biol Chem, 2003,278(42) :40996-41002.
-
8Raber M L, Castillo A, Greer A, et al. A conserved lysine inβ-lactam synthetase assists ring cyclization:implications for clavam and carbapenem biosynthesis [ J ]. Chembio- chem, 2009,10 ( 18 ) : 2904 -2912.
-
9Raber M L, Freeman M F, Townsend C A. Dissection of the stepwise mechanism to β-lactam formation and eluci- dation of a rate-determining conformational change in β-lactam synthetase[ J]. J Biol Chem,2009,284( 1 ) :207- 217.
-
10Raber M L, Arnett S O, Townsend C A. A conserved tyrosyl-glutamyl catalytic dyad in evolutionarily linked enzymes:carba-penam synthetase and β-lactam synthetase [J]. Biochemistry (Mosc) ,2009,48(22) :4959-4971.
引证文献2
-
1黄娟娟,李继安,付骋宇,邵雷.3-羧酸碳青霉烯和硫霉素的生物合成研究进展[J].药学进展,2011,35(1):8-14.
-
2王昭文,翟康,张磊,万克柔,李岳锋.厄他培南合成用钯炭催化剂制备及性能评价[J].工业催化,2020,28(6):46-49.
-
1张义凤,陈昊,彭久合,高瑞昶,张广明.碳青霉烯类抗生素厄他培南的合成[J].中国药科大学学报,2007,38(4):305-310. 被引量：6
-
2史颖,李坤,赵学斌,吕健,孙晓旺.厄他培南钠的合成研究[J].中国抗生素杂志,2011,36(7):519-522. 被引量：5
